In this broadcast: FDA Licenses New Hemophilia Treatment -- Unsafe Use of Extended-Release Tussionex Suspension -- Liver Injury with Tysabri -- Updated Labeling Changes for Tamiflu and Relenza -- New Instructions for Using Talecris IG Syringes -- Hepatotoxicity with Prezista -- Information on Mortality Rates with the AneuRx® Stent Graft System -- Mistakenly Swallowing Inhaler Capsules -- Choosing the Correct Test Strip for a Blood Glucose Meter
In this broadcast: FDA Licenses New Hemophilia Treatment -- Unsafe Use of Extended-Release Tussionex Suspension -- Liver Injury with Tysabri -- Updated Labeling Changes for Tamiflu and Relenza -- New Instructions for Using Talecris IG Syringes -- Hepatotoxicity with Prezista -- Information on Mortality Rates with the AneuRx® Stent Graft System -- Mistakenly Swallowing Inhaler Capsules -- Choosing the Correct Test Strip for a Blood Glucose Meter